Mastek looks attractive for next one year: Sonam Udasi, IDBI Capital
Mastek is consolidating so that could be interesting over the next one year.
Mastek is consolidating so that could be interesting over the next one year.
Don't expect a good valuation for small cap banking stocks: Sonam Udasi, IDBI Capital
Only in a long run depending on the merger ratio that comes out, so I still say that there are pockets that are looking really interesting.
Only in a long run depending on the merger ratio that comes out, so I still say that there are pockets that are looking really interesting.
Midcap pharma moves when overall environment is buoyant: Sonam Udasi, IDBI Capital
Midcap pharma stocks tends to be a little volatile in a three year time frame that said in the current buoyant environment.
Midcap pharma stocks tends to be a little volatile in a three year time frame that said in the current buoyant environment.
There is great interest in exchanges: Sonam Udasi, IDBI Capital
You have also seen what has happened to rating agencies and the kind of re-rating those have got.
You have also seen what has happened to rating agencies and the kind of re-rating those have got.
Metals do not make sense as it tend to be volatile: Sonam Udasi, IDBI Capital
Broad sectors that investors need to look at are banking, autos where really decent amount of re-rating can happen and money can be made over the next two years
Broad sectors that investors need to look at are banking, autos where really decent amount of re-rating can happen and money can be made over the next two years
Buy Aurobindo Pharma with a target price of Rs 205: CK Narayan
Aurobindo Pharma is a ‘BUY’ call with a target of Rs 205 and a stop loss of Rs 192.
Aurobindo Pharma is a ‘BUY’ call with a target of Rs 205 and a stop loss of Rs 192.
Buy Glenmark Pharma with a target price of Rs 510: CK Narayan
Glenmark Pharma is a ‘BUY’ call with a target of Rs 510 and a stop loss of Rs 482.
Glenmark Pharma is a ‘BUY’ call with a target of Rs 510 and a stop loss of Rs 482.
Buy Gitanjali Gems with a target price of Rs 505: Ashwani Gujral
Gitanjali Gems is a ‘BUY’ call with a target of Rs 505 and a stop loss of Rs 473.
Gitanjali Gems is a ‘BUY’ call with a target of Rs 505 and a stop loss of Rs 473.
Sell Reliance Capital with a target price of Rs 455: Ashwani Gujral
Reliance Capital is a ‘SELL’ call with a target of Rs 455 and a stop loss of Rs 481.
Reliance Capital is a ‘SELL’ call with a target of Rs 455 and a stop loss of Rs 481.
No comments:
Post a Comment